Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating hyperammonemia, reducing plasma ammonia with TLR4 antagonists

Treating hyperammonemia, reducing plasma ammonia with TLR4 antagonists

US Patent 10639346 · Granted May 5, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of pyroptosis2023
Treatment of necroptosis2023
Treatment of portal hypertension and restoration of liver function using L-ornit2022
Treatment of diseases associated with hepatic stellate cell activation using amm2021
Compositions comprising ornithine and phenylacetate or phenylbutyrate for treati2020
Treatment of diseases associated with hepatic stellate cell activation using amm2020
Treatment of diseases associated with hepatic stellate cell activation using amm2018
Treating renal and liver dysfunction with TLR4 antagonists2018
Treating renal and liver dysfunction with TLR4 antagonists2018
Porous carbon particles for use in the treatment or prevention of liver disease2017
Compositions comprising ornithine and phenylacetate or phenylbutyrate for treati2017
Therapy for liver disease2013